CLINICAL_TRIALS
trial_result
· 2012-07-17
Clinical Trial Update: Efficacy Study of Dasatinib in Locally Advanced Triple-Negative Breast Cancer Patients [Phase 2]
Summary
A Phase 2 study evaluating dasatinib in locally advanced triple-negative breast cancer was terminated, with results posted in 2012.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Baylor Breast Care Center | Conditions: Breast Cancer | Phase 2 | Status: TERMINATED | Results posted: 2012-07-17